Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1997 1
1998 1
2001 1
2002 1
2005 1
2009 1
2010 1
2011 1
2012 4
2013 4
2014 3
2015 1
2016 1
2017 1
2018 1
2020 1
2021 3
2022 1
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
Outteryck O, Zéphir H, Salleron J, Ongagna JC, Etxeberria A, Collongues N, Lacour A, Fleury MC, Blanc F, Giroux M, de Seze J, Vermersch P. Outteryck O, et al. Among authors: ongagna jc. Mult Scler. 2014 Jun;20(7):822-9. doi: 10.1177/1352458513505353. Epub 2013 Sep 26. Mult Scler. 2014. PMID: 24072722
Reduction of the washout time between natalizumab and fingolimod.
de Seze J, Ongagna JC, Collongues N, Zaenker C, Courtois S, Fleury M, Benoilid A, Chanson JB, Blanc F; Alsacep Network. de Seze J, et al. Among authors: ongagna jc. Mult Scler. 2013 Aug;19(9):1248. doi: 10.1177/1352458513490551. Epub 2013 May 30. Mult Scler. 2013. PMID: 23722322 No abstract available.
Long-term effect of natalizumab in patients with RRMS: TYSTEN cohort.
Bigaut K, Fabacher T, Kremer L, Ongagna JC, Kwiatkowski A, Sellal F, Ferriby D, Courtois S, Vermersch P, Collongues N, Zéphir H, De Seze J, Outteryck O. Bigaut K, et al. Among authors: ongagna jc. Mult Scler. 2021 Apr;27(5):729-741. doi: 10.1177/1352458520936239. Epub 2020 Jul 9. Mult Scler. 2021. PMID: 32643521
CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.
Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks. Pignolet B, et al. Among authors: ongagna jc. Neurology. 2016 Dec 6;87(23):2491-2494. doi: 10.1212/WNL.0000000000003401. Epub 2016 Nov 4. Neurology. 2016. PMID: 27815407 Clinical Trial. No abstract available.
Predictors of mortality, ICU hospitalization, and extrapulmonary complications in COVID-19 patients.
Martinot M, Eyriey M, Gravier S, Bonijoly T, Kayser D, Ion C, Mohseni-Zadeh M, Camara S, Dubois J, Haerrel E, Drouaine J, Kaiser J, Ongagna JC, Schieber-Pachart A, Kempf C; Centre Alsace COVID-19 Study Group. Martinot M, et al. Among authors: ongagna jc. Infect Dis Now. 2021 Sep;51(6):518-525. doi: 10.1016/j.idnow.2021.07.002. Epub 2021 Jul 7. Infect Dis Now. 2021. PMID: 34242842 Free PMC article.
Long-term follow-up of acute partial transverse myelitis.
Bourre B, Zéphir H, Ongagna JC, Cordonnier C, Collongues N, Debette S, Fleury MC, Outteryck O, Hannequin D, Vermersch P, de Seze J. Bourre B, et al. Among authors: ongagna jc. Arch Neurol. 2012 Mar;69(3):357-62. doi: 10.1001/archneurol.2011.949. Arch Neurol. 2012. PMID: 22410443
22 results